A Specialty Consolidator: Biopharma Aytu Looks To Acquisitions And Licensing To Propel Growth ...

Retrieved on: 2021-01-06 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

A Specialty Consolidator: Biopharma Aytu Looks To Acquisitions And Licensing To Propel Growth .... View article details on hiswai:

Excerpt

(NASDAQ: AYTU), led by its founders and biopharmaceutical entrepreneurs Jarrett and Josh Disbrow, is among the companies within the industry ...

Article found on: www.benzinga.com